Picture of Fagron NV logo

FAGR Fagron NV Share Price

0.000.00%
be flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Momentum

Relative Strength (%)
1m-0.3%
3m+8.28%
6m+25.27%
1yr-3.09%
Volume Change (%)
10d/3m-41.54%
Price vs... (%)
52w High-7.43%
50d MA-0.12%
200d MA+18.09%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)15.23
PEG Ratio (f)2.02
EPS Growth (f)8.15%
Dividend Yield (f)1.7%
Valuation (ttm)IndustryMarket
Price to Book Value3.02
Price to Tang. Bookn/a
Price to Free Cashflow13.43
Price to Sales1.79
EV to EBITDA11.62

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital12.24%
Return on Equity19.21%
Operating Margin14.32%

Financial Summary

Year End 31st DecUnit201820192020202120222023E2024ECAGR / Avg
Total Revenue€m471.68534.7555.97573.81683.88740791.69.54%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-6.42+26.73+8.71+0.02+17.81+0.67+17.88n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Fagron NV EPS forecast chart

Profile Summary

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and development (R&D) team; Fagron Essentials comprises pharmaceutical raw materials, equipment and supplies for pharmacies, and the HL Technology segment includes the development and production of precision components and orthopedic tools for dental and medical professionals.

Directors

Last Annual
December 31st, 2022
Last Interim
December 31st, 2022
Incorporated
July 3rd, 2007
Public Since
October 5th, 2007
No. of Employees
3,162
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
be flag iconEuronext - Brussels
Shares in Issue
73,125,277
Blurred out image of a map
Address
Venecoweg 20A, NAZARETH, 9810
Web
https://fagron.com/
Phone
+32 80012880
Auditors
Deloitte Bedrijfsrevisoren

FAGR Share Price Performance

Upcoming Events for FAGR

Q2 2023 Fagron NV Earnings Release

Q3 2023 Fagron NV Trading Statement Release

Q3 2023 Fagron NV Earnings Release

Similar to FAGR

Picture of Bone Therapeutics SA logo

Bone Therapeutics SA

be flag iconEuronext - Brussels

Picture of Hyloris Pharmaceuticals SA logo

Hyloris Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

be flag iconEuronext - Brussels

Picture of Financiere de Tubize SA logo

Financiere de Tubize SA

be flag iconEuronext - Brussels

Picture of UCB SA logo

UCB SA

be flag iconEuronext - Brussels

FAQ

Or unlock with your email

Or unlock with your email